Showing results (1581-1590 of 1,707) with videos related to
Sort By:
Pageof 171
Public Health Nursing (Boston, Mass.)|January 5, 2022
Community-based multiple screening for metabolic syndrome by innovative theory: A longitudinal studyAngela Shin-Yu Lien, Sherry Yueh-Hsia Chiu, Sam Li-Sheng Chen, et al.International Journal of Cancer|January 22, 2002
Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrumWei-min Cheng, Kwok Hung Chan, Hong-lin Chen, et al.General Hospital Psychiatry|October 10, 2012
Association between uremic toxins and depression in patients with chronic kidney disease undergoing maintenance hemodialysisHeng-Jung Hsu, Chiung-Hui Yen, Chih-Ken Chen, et al.Eclinicalmedicine|August 20, 2025
An artificial intelligence model integrating culprit lesion diagnosis and risk assessment for acute coronary syndromePeng Peng Xu, Bin Hu, Fan Zhou, et al.Journal of the American Heart Association|October 8, 2024
Installation of Public Access Defibrillators for Out-of-Hospital Cardiac Arrests: Identifying Suitable Locations by Using a Geographic Information SystemChen-Bin Chen, Ming-Fang Wang, Chen-June Seak, et al.The American Journal of Emergency Medicine|July 4, 2007
Predictive model of antimicrobial-resistant gram-negative bacteremia at the EDWen-Chu Chiang, Shey-Ying Chen, Kuo-Liong Chien, et al.Cell Death Discovery|November 1, 2023
NTRK1 knockdown induces mouse cognitive impairment and hippocampal neuronal damage through mitophagy suppression via inactivating the AMPK/ULK1/FUNDC1 pathwayKai Yang, Jue Wu, Shang Li, et al.Head & Neck|October 13, 2020
Impact of treatment delay on survival of oral/oropharyngeal cancers: Results of a nationwide screening programWilliam Wang-Yu Su, Yi-Huah Lee, Amy Ming-Fang Yen, et al.Cancer|January 12, 2021
Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 studyKeunchil Park, Pasi A Jӓnne, Dong-Wan Kim, et al.Cancer|May 22, 2015
Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening ProgramHan-Mo Chiu, Sam Li-Sheng Chen, Amy Ming-Fang Yen, et al.Pageof 171